Sphere Medical has 141,757,872 Ordinary Shares of nominal value £0.01 each in issue.


The Wales Life Sciences Investment Fund 25,000,000 17.64%

Woodford Patient Capital Trust Plc 23,125,000 16.31%

LSP Life Sciences Fund 10,904,000 7.69%

Ortho-Clinical Diagnostics 8,141,250 5.74%

Fidelity Worldwide Investments 6,264,649 4.42%

Octopus Investments 6,250,000 4.41%

Ruffer LLP 5,653,895 3.99%

Royal London Asset Management 5,624,185 3.97%

Herald Investment Management 4,711,965 3.32%





Should be an exciting year ahead with developments.
Anybody had a look at this company?

Hope some good news reported tonight!!!

http://www.shareprice.co.uk/SPHR/SPHERE-MEDICAL-ORD-1P
Good progress...

Cambridge boost for bypass surgery patients

Technology from medical device business Sphere Medical Holding has achieved positive results in trials with anaesthetists involved in bypass surgery at Papworth Hospital in Cambridge UK.
The results will be presented at the Society for Intravenous Anaesthesia Annual Scientific Meeting in Edinburgh on November 29 and 30 and Sphere hopes it will soon be able to drive the product to market in the UK and Japan.

The Cambridge company reports that Pelorus 1500, the world’s first in-vitro diagnostic medical device for the rapid measurement of the intravenous anaesthetic propofol at the point of care, has met its primary end point in the clinical study. It has demonstrated equivalent performance to a gold standard method of analysis, Sphere says.

A total of 111 whole blood samples from 32 patients undergoing cardiopulmonary bypass surgery at Papworth Hospital were analysed. Each sample was tested using both Sphere Medical’s Pelorus 1500 and the current gold standard High Performance Liquid Chromatography (HPLC) reference test. The results from the Pelorus 1500 were said “to show excellent agreement with the reference method.”

Sphere Medical is working with a number of the UK’s leading anaesthetists to investigate novel approaches to take propofol measurements during infusion with the aim of allowing anaesthetists to know the actual – rather than predicted – concentration of propofol thereby creating the personalisation of dosing to the patient.

Have purchased another 400,000 shares to add to their holding..
Holding was 1,331,081 shares......
Now 1,799,363 shares......

Looks a good tie up...

Starting to create some attention and buying..at last......

There is an awful lot of buying in those trades..even my trades are marked as sells?????

Some blue coming through now...seller seems to have cleared....

Shareprophet has tipped this stock recently....large seller has now cleared.......

Got ce approval for Proxima device....Launching device tomorrow.....
Looks interesting now for a punt...imho....:-)

Woodford's first fund investment.....

Proposed Placing and Open Offer



Cambridge, UK, 13 April 2015: Sphere Medical Holding plc (AIM: SPHR.L), a leading provider of innovative monitoring and diagnostic devices for the critical care setting, today announces that it is planning to raise, subject to certain conditions, approximately £12 million (before expenses), by way a Placing pursuant to which 75,000,000 New Ordinary Shares will be issued at 16 pence each to new and existing investors.

Woodford Investment Management, on behalf of its clients, has given a non-binding intent to invest up to £4 million in the Placing and the Wales Fund (being a fund raising up to £100 million focused on life sciences and managed by Arthurian), has given a conditional commitment to invest £4 million in the Placing. The Placing Shares have been conditionally placed by the Joint Brokers with new and existing institutional investors other than those which may be subscribed for by Woodford Investment Management, on behalf of its clients.

Could be finally turning a corner...

You haven't added a EPIC to your thread

Where do I do that or is it to late?

It's not something that we mere mortals can do, but it may be worth asking Ian to do it on this thread.

Thank you guys!!

Ah...still no epic....:-(

29 April 2015

Sphere Medical Holding plc

Result of Open Offer

Cambridge, UK, 29 April 2015: Sphere Medical Holding plc (AIM: SPHR.L), ("Sphere Medical" or the "Company") a leading provider of innovative monitoring and diagnostic devices for the critical care setting, announced on 13 April 2015 details of the Company's proposed fundraising through a Placing and Open Offer at 16 pence per share.

The last time and date for receipt of completed application forms and payment in full under the Open Offer was 11.00 a.m. on 28 April 2015. The Company announces that at that time that it had received valid acceptances in respect of 7,352,582 Open Offer Shares from Qualifying Shareholders with a value of some GBP1,176,413. This represents approximately 99% of the 7,425,661 Open Offer Shares offered. As a consequence, the Company has conditionally raised GBP13.2 million (before expenses) through the Placing and Open Offer.

The Placing and Open Offer are all subject to the approval of Shareholders at a General Meeting to be held at 10.00 a.m. on 30 April 2015.

Application has been made to AIM, a market of the London Stock Exchange plc, for the admission of 82,352,582 New Ordinary Shares to be issued pursuant to the Placing and Open Offer. It is expected that Admission will become effective on 1 May 2015. Following Admission, the Company will have 141,757,872 Ordinary Shares in issue.

The New Ordinary Shares, when issued and fully paid will rank equally in all respects with the Existing Ordinary Shares.

Commenting on today's announcement, Dr. Wolfgang Rencken, Chief Executive Officer of Sphere Medical, said:

"We are very appreciative of the continued support from a significant number of our long-term shareholders that have taken part in this Open Offer. The proceeds from the fundraising will further strengthen the Company's balance sheet as we accelerate the commercialisation of Proxima in Europe."

Unless otherwise defined, terms in this announcement shall have the same meanings as those defined in the shareholder circular dated 13 April 2015.

I have today bought a very small holding in this stock. It's not my typical type of play as I prefer stocks with a track record and something I can latch onto.

My rationale is as follows:
1. After a number of years the product is moving to the point of real sales. The market would appear to be huge but it is difficult to quantify how fast sales will increase. I suspect it will be slower than most would like but I am patient.

2. Neil Woodford took up £4m shares at 16p and if 16p is good enough for him I'm happy to take my chances at 16.8p

3. After the placing the shares inevitably fell but I am surprised they have come all the way back to the placing price. I guess someone took up the placing but didn't really want the shares and is selling the placing shares at a profit.

4. There is a daily flow of buys which sooner or later will soak up whoever is selling. Dont' be confused by the trade pattern - all those sells reported at 16.8p are buys.

5. The directors took part in the open offer and put their own money in.

diagnostic devices , have a poor track record, buy after the next loss a/c 12pence ?

16.80p have all been buys as I have added but it was marked down as red....
No issues as I believe this will move quickly when it turns....